These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8595281)

  • 21. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States.
    Altekruse SF; Lacey JV; Brinton LA; Gravitt PE; Silverberg SG; Barnes WA; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Hildesheim A
    Am J Obstet Gynecol; 2003 Mar; 188(3):657-63. PubMed ID: 12634637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities.
    Burger MP; Hollema H; Pieters WJ; Quint WG
    BMJ; 1995 Jan; 310(6972):94-5. PubMed ID: 7833734
    [No Abstract]   [Full Text] [Related]  

  • 25. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
    Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
    J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.
    Luostarinen T; Lehtinen M; Bjørge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie AK; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman LD; Dillner J; Hakulinen T
    Eur J Cancer; 2004 May; 40(7):1058-65. PubMed ID: 15093583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection and invasive cervical cancer in Paraguay.
    Rolón PA; Smith JS; Muñoz N; Klug SJ; Herrero R; Bosch X; Llamosas F; Meijer CJ; Walboomers JM
    Int J Cancer; 2000 Feb; 85(4):486-91. PubMed ID: 10699919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
    Sasagawa T; Basha W; Yamazaki H; Inoue M
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
    Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S;
    Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia trachomatis and cervical squamous cell carcinoma.
    Gravitt PE; Castle PE
    JAMA; 2001 Apr; 285(13):1703-4; author reply 1705-6. PubMed ID: 11277819
    [No Abstract]   [Full Text] [Related]  

  • 31. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
    Kapeu AS; Luostarinen T; Jellum E; Dillner J; Hakama M; Koskela P; Lenner P; Löve A; Mahlamaki E; Thoresen S; Tryggvadóttir L; Wadell G; Youngman L; Lehtinen M
    Am J Epidemiol; 2009 Feb; 169(4):480-8. PubMed ID: 19074773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum selenium and the risk of cervical cancer among women in the United States.
    Thompson FE; Patterson BH; Weinstein SJ; McAdams M; Spate VL; Hamman RF; Levine RS; Mallin K; Stolley PD; Brinton LA; Morris JS; Ziegler RG
    Cancer Causes Control; 2002 Aug; 13(6):517-26. PubMed ID: 12195641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus in carcinogenesis of cervical cancer.
    de Silva NR; Mendis L; Perera N
    Ceylon Med J; 1999 Mar; 44(1):45-7. PubMed ID: 10643100
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus, but presence of a multiple human papillomavirus infection.
    Bais AG; Kooi S; Teune TM; Ewing PC; Ansink AC
    Gynecol Oncol; 2005 May; 97(2):716-8. PubMed ID: 15863191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
    Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
    J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second primary cancer after in situ and invasive cervical cancer.
    Hemminki K; Dong C; Vaittinen P
    Epidemiology; 2000 Jul; 11(4):457-61. PubMed ID: 10874555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer.
    Dillner J; Knekt P; Boman J; Lehtinen M; Af Geijersstam V; Sapp M; Schiller J; Maatela J; Aromaa A
    Int J Cancer; 1998 Feb; 75(4):564-7. PubMed ID: 9466657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland.
    Lehtinen M; Hakama M; Aaran RK; Aromaa A; Knekt P; Leinikki P; Maatela J; Peto R; Teppo L
    Cancer Causes Control; 1992 Jul; 3(4):333-8. PubMed ID: 1617120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up.
    Hakama M; Lehtinen M; Knekt P; Aromaa A; Leinikki P; Miettinen A; Paavonen J; Peto R; Teppo L
    Am J Epidemiol; 1993 Jan; 137(2):166-70. PubMed ID: 8452120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.